Potency
600B CFU/g
Formulation
Lacticaseibacillus casei
Pediococcus acidilactici
Lactobacillus acidophilus
Lactiplantibacillus plantarum
Bifidobacterium animalis subsp. lactis
It effectively promotes the proliferation of macrophages RAW264.7, increases the phagocytosis index of RAW264.7 cells, promotes the production of TNF-α, IL-10 and other cytokines, and plays an immune regulatory role. At the same time, this strain has a broad antibacterial spectrum and can effectively inhibit pathogenic bacteria such as Staphylococcus aureus, Escherichia coli, Salmonella, Streptococcus mitis, and Klebsiella pneumoniae.
It effectively inhibits the growth of Listeria monocytogenes, has a protective effect on intestinal epithelial cell strain (HT-29) infection and mouse liver and spleen infection caused by Listeria monocytogenes, can protect immune organs, and has immunomodulatory potential.
Animal experiments show that LA85 can protect immune organs, regulate protein expression in related pathways, and play an immune regulatory role. At the same time, LA85 can effectively inhibit pathogenic bacteria such as Escherichia coli, Salmonella and Staphylococcus aureus.
High-yield extracellular polysaccharides can improve the proliferation and phagocytosis ability of macrophages RAW264.7, play an immune regulatory role, and can also efficiently scavenge free radicals and inhibit pathogens.
BLa36 can regulate the intestinal flora by increasing the alpha diversity of intestinal flora and increasing the relative abundance of beneficial bacteria, improving intestinal peristalsis, assisting digestion and absorption, nourishing blood and calming the mind.
100,000 level (partial 10,000 level) GMP purification workshop,
Constant temperature (28℃)
Constant humidity (35%) environment
We adhere to using safe and portable packaging, with our products enclosed in triple-layered, high-barrier composite aluminum foil bags, which ensures the isolation of probiotics from external air, and guaranteeing the viability of the probiotics effectively.